It Took a Text From Joe Rogan. Now Psychedelics Are a Federal Research Priority.
President Trump signed an executive order on April 18 directing the FDA to fast-track review of psychedelic therapies and committing $50 million to ibogaine research. The psychedelics community is cautiously optimistic, and watching closely. President Donald Trump signed an executive order on Saturday directing federal agencies to accelerate research into psychedelic therapies and allocating $50 […]
Why Some Heavy Cannabis Users Can’t Stop Throwing Up, According to New Research
A survey of more than 1,100 people with suspected or diagnosed CHS offers one of the clearest looks yet at the condition, including a notable finding: exclusive vape cartridge users reported symptoms appearing sooner than exclusive flower smokers. By Riley Kirk, PhD and Codi Peterson, PharmD Cannabis is known for helping fight nausea. It can […]
Mississippi Governor Vetoes Bills To Expand Medical Marijuana Access, But Signs Psychedelic Research Measure
Mississippi’s governor has vetoed a pair of bills to expand medical marijuana access while signing separate legislation to support research in hopes of gaining federal approval for the psychedelic ibogaine as a novel treatment option. Lawmakers approved each measure by strong margins, but on Thursday Gov. Tate Reeves (R) rejected the cannabis proposals while accepting […]
Bipartisan Senators File Bill To Support Psychedelics Research And Treatment For Veterans
A bipartisan group of U.S. senators have introduced a bill to promote research into the therapeutic potential psychedelics by creating a new office in the Department of Veterans Affairs (VA) that would advance the development innovative treatments for serious mental health conditions and assist in reviewing the scheduling status of drugs like psilocybin, ibogaine and […]
GOP Senator To File Bill Promoting Psychedelics Research And Treatment For Veterans
A new Senate bill is being filed that would promote research into the therapeutic potential psychedelics, aiming to create a new office in the Department of Veterans Affairs (VA) that would advance the development innovative treatments for serious mental health conditions and assist in reviewing the scheduling status of drugs like psilocybin, ibogaine and MDMA. […]